1. SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia;Cines;N Engl J Med,2021
2. Endothelial cell dysfunction: a major player in SARS-CoV-2 infection (COVID-19)?;Huertas;Eur Respir J,2020
3. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia;Tang;J Thromb Haemost JTH,2020
4. World Health Organization. Global Advisory Committee on Vaccine Safety (GACVS) review of latest evidence of rare adverse blood coagulation events with AstraZeneca COVID-19 Vaccine (Vaxzevria and Covishield) [Internet]. Disponible en: https://www.who.int/news/item/16-04-2021-global-advisory-committee-on-vaccine-safety-(gacvs)-review-of-latest-evidence-of-rare-adverse-blood-coagulation-events-with-astrazeneca-covid-19-vaccine-(vaxzevria-and-covishield). (Accessed Decembe 1, 2021 ).
5. COVID-19 Vaccines and Thrombosis-Roadblock or Dead-End Street?;Lundstrom;Biomolecules,2021